Effect of Intermittent Fasting, Probiotic-Fermented Camel Milk, and Probiotic-Fermented Camel Milk Incorporating Sukkari Date on Diet-Induced Obesity in Rats

• Published in: Fermentation (Basel) Vol. 8; no. 11; p. 619
• Main Authors: Aljutaily, Thamer, Rehan, Medhat, Moustafa, Mahmoud M. A, Barakat, Hassan
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 01-11-2022
• Subjects: Adiponectin; Adipose tissue; antioxidant status; Antioxidants; Blood glucose; Body weight; Body weight loss; Camel's milk; Catalase; Diabetes; Diet; Fasting; Fatty acids; fermented camel milk; Fermented milk; Fermented milk products; Food; Glutathione; Health aspects; High density lipoprotein; histopathological alterations; Inflammation; Leptin; Lipolysis; Lipoproteins (very low density); Low density lipoprotein; Metabolic syndrome; Metabolites; Microbiota; Milk; Nutrition research; Obesity; Oxidative stress; Parenchyma; Physiological aspects; Probiotics; Proteins; Rodents; Superoxide dismutase; Triglycerides; Weight control; United States
• ISSN: 2311-5637; 2311-5637
• DOI: 10.3390/fermentation8110619

Obesity causes metabolic syndrome disorders that are detrimental to health. The current study examined the effects of intermittent fasting (IF), fermented camel milk (FCM), and fermented camel milk incorporating 10% Sukkari date (FCM-D) on weight loss, blood profile, and antioxidant status in obese rats for 6 weeks. Subsequently, leptin and adiponectin levels and histopathological examination of adipose tissue were carried out. Results showed that IF with FCM or FCM-D decreased body weight by 0.92 and −5.45%, respectively. IF alone lowered non-fasting blood glucose (NFBG) and fasting blood glucose FBG after 6 weeks, whereas adding FCM or FCM-D reduced NFBG after 4 weeks. Intermittently fasting obese rats given FCM or FCM-D had the lowest blood glucose levels (BGL). The hypolipidemic effects of IF, FCM, and FCM-D on obese rats reduced triglycerides (TG), cholesterols (CHO), and their derivatives. FCM-D with IF presented a superior effect on lipid profile. A reduction rate of 40, 37, 66, and 40% for TG, CHO, low-density lipoprotein (LDL-c), and very low-density lipoprotein (VLDL-c), respectively, and an increase in HDL-C by 34% were noticed. Reductions of 40, 37, 66, and 40% for TG, CHO, LDL-c, and VLDL-c, respectively, and a 34% rise in high-density lipoprotein (HDL-C) were noted. Combining IF with FCM or FCM-D lowered the atherogenic index (AI) by 42% and 59%, respectively. Remarkably, treating rats with FCM+IF or FCM-D+IF effectively attenuated leptin and adiponectin levels. Malondialdehyde (MDA) was significantly decreased in a type-dependent manner. Implementing FCM-D or FCM with IF significantly attenuated reduced glutathione (GSH), superoxide dismutase (SOD), MDA, and catalase (CAT) levels. The most efficient treatment was giving FCM-D with IF. Histopathologically, adipocyte lipolysis increases free fatty acids (FFAs) and promotes inflammation. Only IF+FCM-D indicated no histopathological alteration except for a few focal areas of a few inflammatory cell infiltrations in the parenchyma. In conclusion, combining IF and Probiotic-FCM or Probiotic-FCM-D effectively accelerated weight loss, attenuated metabolic markers, and reversed histopathological alterations. Thus, IF combined with Probiotic-FCM or Probiotic-FCM-D is highly recommended for weight loss, strengthening antioxidative status, and preventing health disorders.